Halozyme Inc. (HALO) Bozor kapitallashuvining balans qiymatiga nisbati
Halozyme Therapeutics (HALO) innovatsion teri osti dori yetkazib berish usulini litsenziyalash orqali daromad keltiradi va sezilarli miqdorda royalti to'lovlarini yig'adi. GURU.Markets platformasidagi bozor va kitob qiymati ko'rsatkichlari grafigi narxlar dinamikasini aks ettiradi, bunda joriy qiymat 104.91 darajasida turibdi. Narxlar barqarorligi fermentlarning optimallashtirilgan taqsimoti bilan ta'minlanadi, biznes esa ishlab chiqarishni tashqi kontrakt hamkorlariga topshirish orqali autsorsingga tayanadi.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_HALO_-_Halozyme-Therapeutics_-_Market-Cap-to-Net-Assets-Ratio "Halozyme Inc. (HALO) Bozor kapitallashuvining balans qiymatiga nisbati: 04.07.2022 - 30.10.2026 davri uchun | 👁️GURU.Markets👁️")
Halozyme Therapeutics, Inc. (HALO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi tafsilotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Halozyme Therapeutics|HALO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Halozyme Inc.|HALO - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Halozyme Inc.|HALO - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Halozyme|Tezkor likvidlik koeffitsiyenti halozyme.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Halozyme Therapeutics
Ushbu ko'rsatkich investor kompaniyaning sof aktivlarining har bir dollari uchun to'laydigan bozor premiumi hajmini belgilaydi va bu aktivlarning haqiqiy qiymatini bozor kutganlari bilan farqlash imkonini beradi. Enhanze texnologiyasini litsenziyalashdan olinadigan diversifikatsiyalangan royalti oqimi bilan barqarorligi ta'minlangan Halozyme Therapeutics (HALO) uchun bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati intellektual mulk biznesning fundamental baholanishi doirasida qanchalik kapitalizatsiya qilinganini aks ettiradi.
Halozyme Therapeutics kimlar bilan raqobatlashadi
BeiGene Ltd (ONC) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti revmed.com (RVMD)|AAPG (Ascentage Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CG Oncology Inc (CGON)|Bozor kapitallashuvining balans qiymatiga nisbati URGN|Bozor kapitallashuvining balans qiymatiga nisbati Bicara Corp (BCAX)|Bozor qiymatining balans qiymatiga nisbati Personalis, Inc. PSNL|ERAS: Kapitallashuvning balans qiymatiga nisbati|Delcath Systems - Bozor kapitallashuvining balans qiymatiga nisbati|Y-mAbs Therapeutics Inc (YMAB) - Kapitallashuvning sof aktivlarga nisbati|AURA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Candel Therapeutics, Inc. (CADL)|Bozor qiymatining balans qiymatiga nisbati Accuray Incorporated|SLS: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACTU (Actuate Therapeutics)|CTOR (Citius Oncology Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati HURA (TuHURA Biosciences)|TARA - Kapitallashuvning sof aktivlarga nisbati|FATE: Kapitallashuvning sof aktivlarga nisbati|WHWK - Bozor kapitallashuvining balans qiymatiga nisbati|tscan.com (TCRX) - Bozor qiymatining balans qiymatiga nisbati|Champions Oncology, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Bozor kapitallashuvining balans qiymatiga nisbati OSTX|RADX (Radiopharm Theranostics Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Bozor kapitallashuvining balans qiymatiga nisbati Adlai Nortye Ltd ANL|VERU - Bozor qiymatining balans qiymatiga nisbati|TPST: Bozor qiymatining balans qiymatiga nisbati|xiliotx.com (XLO) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Renovaro (RENB)|Kapitallashuvning sof aktivlarga nisbati MURA|Kairos Pharma Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati OKUR (OnKure Therapeutics Inc)|GDTC - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Curis CRIS|APLM - Kapitallashuvning sof aktivlarga nisbati|Tharimmune - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Advanced Biomed Inc|GNPX (Genprex, Inc) - Kapitallashuvning sof aktivlarga nisbati|Calidi Biotherapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SBFM|XBIO (Xenetic Bio) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati SLRX|PPBT (Purple Biotech Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|BeiGene Ltd (BGNE) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CKPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati ELEV (Elevation Oncology Inc.)|ICAD: Bozor kapitallashuvining balans qiymatiga nisbati|Ikena Oncology (IKNA) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Viracta - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MOR|NAYA - Bozor qiymatining balans qiymatiga koeffitsiyenti|Ascentage Pharma - Kapitallashuvning sof aktivlarga nisbati